PC
CDLX icon

Pier Capital’s Cardlytics CDLX Stock Holding History

Pier Capital’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,319
Closed -$1.93M – 128
2024
Q1 		$1.93M Buy
+13,319
New +$1.12M 0.27% 95
2022
Q3 		– Sell
-12,009
Closed -$2.68M – 105
2022
Q2 		$2.68M Sell
12,009
-3,172
-21% -$1.06M 0.46% 88
2022
Q1 		$8.35M Sell
15,181
-104
-0.7% -$62.9K 1.07% 52
2021
Q4 		$10.1M Buy
15,285
+2,949
+24% +$2.25M 1.07% 52
2021
Q3 		$10.4M Buy
12,336
+3,547
+40% +$3.6M 1.07% 49
2021
Q2 		$11.2M Sell
8,789
-667
-7% -$753K 1.12% 39
2021
Q1 		$10.4M Buy
9,456
+495
+6% +$654K 0.98% 63
2020
Q4 		$12.8M Sell
8,961
-3,290
-27% -$3.51M 1.35% 6
2020
Q3 		$8.64M Buy
12,251
+5,606
+84% +$4.08M 1.26% 12
2020
Q2 		$4.65M Sell
6,645
-5,267
-44% -$3.04M 0.74% 82
2020
Q1 		$4.16M Sell
11,912
-657
-5% -$465K 0.92% 56
2019
Q4 		$7.9M Sell
12,569
-10,115
-45% -$4.95M 1.29% 24
2019
Q3 		$7.6M Buy
+22,684
New +$7.27M 1.29% 24

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pier Capital's CDLX Position: Q2 2024 in Review

Pier Capital sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 13,319 shares — an estimated $1.93M sold.

Pier Capital first reported a position in CDLX in Q3 2019 and held it in 13 quarters. The position peaked at $12.8M in Q4 2020. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Pier Capital reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Pier Capital sold 13,319 Cardlytics shares in Q2 2024, an estimated $1.93M.
  • Pier Capital first reported a position in Cardlytics in Q3 2019 and held it in 13 quarters.
  • Pier Capital's Cardlytics position peaked at $12.8M in Q4 2020.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Pier Capital's 13F filing for Q2 2024, filed 7 Aug 2024.